Primary prevention of sudden cardiac death in silent cardiac sarcoidosis role of programmed ventricular stimulation

Circulation: Arrhythmia and Electrophysiology

Volumn 4, Issue 1, 2011, Pages 43-48

  Mehta, Davendra ^a   Mori, Neil ^a   Goldbarg, Seth H ^a   Lubitz, Steven ^a   Wisnivesky, Juan P ^a   Teirstein, Alvin ^a  

^a MOUNT SINAI HOSPITAL   (United States)

Author keywords

Arrhythmia; Cardiomyopathy; Electrophysiology; Magnetic resonance imaging; Sudden death

Indexed keywords

ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; ECHOCARDIOGRAPHY; EVALUATION AND FOLLOW UP; FEMALE; HEART ARRHYTHMIA; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART SARCOIDOSIS; HEART STIMULATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRAMMED ELECTRIC STIMULATION; SARCOIDOSIS; SUDDEN DEATH; SURVIVAL RATE; ADULT; CARDIOMYOPATHY; FOLLOW UP; HEART FUNCTION TEST; HEART STROKE VOLUME; HEART VENTRICLE FUNCTION; KAPLAN MEIER METHOD; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

ADULT; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RISK FACTORS; SARCOIDOSIS; STROKE VOLUME; VENTRICULAR DYSFUNCTION;

EID: 79953782445     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.110.958322     Document Type: Article

References (17)

1. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58: 1204-1211. (Pubitemid 9092005)
2. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med. 1977; 63:86-108. (Pubitemid 8146656)
3. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLellan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885-1889. (Pubitemid 33152325)
4. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, duBios R, Eklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos O, Semenzato G, Sharma OP. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:149-173.
5. Yamagishi H, Shirai N, Takagi M, Yoshiyama M, Akioka K, Takeuchi K, Yoshikawa J. Identification of cardiac sarcoidosis with (13)N-NH(3)/ (18)F-FDG PET. J Nucl Med. 2003;44:1030-1036. (Pubitemid 39663376)
6. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM, Kim RJ. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009; 120:1969-1977.
7. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225-237. (Pubitemid 40110811)
8. Lee KL, Hafley G, Fisher JD, Gold MR, Prystowsky EN, Talajic M, Josephson ME, Packer DL, Buxton AE. Effect of implantable defibril-lators on arrhythmic events and mortality in the multicenter unsustained tachycardia trial. Circulation. 2002;106:233-238. (Pubitemid 34761305)
9. Cheong BY, Muthupillai R, Nemeth M, Lambert B, Dees D, Huber S, Castriotta R, Flamm SD. The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2009;26:39-46.
10. Aizer A, Stern EH, Gomes JA, Teirstein AS, Eckart RE, Mehta D. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol. 2005;96:276-282. (Pubitemid 40978589)
11. Griner PF, Mayewski RJ, Mushlin AI, Greenland P. Selection and interpretation of diagnostic tests and procedures. Principles and applications. Ann Intern Med. 1981;94:557-592.
12. Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramatsu S, Nakano T, Izumi T, Sekiguchi M. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88:1006-1010. (Pubitemid 33042612)
13. Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, Ito N, Ohiro H, Ikeda D, Tamaki N, Nishimura M. Focal uptake on 18F-fluoro-2- deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J. 2005;26: 1538-1543. (Pubitemid 41373496)
14. Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, SMcNitt S, Huang DT, Moss AJ. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defi-brillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol. 2006;47:98-107. (Pubitemid 43005171)
15. Das SK, Morady F, DiCarlo L Jr, Baerman J, Krol R, De Buitleir M, Crevey B. Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias. Am J Cardiol. 1986;58:998-1000. (Pubitemid 17175841)
16. Poll DS, Marchlinski FE, Buxton AE, Josephson ME. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol. 1986;58:992-997. (Pubitemid 17175840)
17. Winters SL, Cohen M, Greenberg S, Stein B, Curwin J, Pe E, Gomes JA. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol. 1991;18:937-943.